Care for People Living with Amyloidosis
Amyloidosis is a complicated group of diseases where an abnormal protein, called amyloid, can affect one or several organs. The organs involved include the bone marrow, heart, kidneys, nervous systems, gastrointestinal tract, and more.
The BIDMC Amyloidosis Clinic provides comprehensive diagnostic and therapeutic services for patients with amyloidosis. The program is staffed by a multidisciplinary team of experts in Cardiology (including Advanced Heart Failure, Electrophysiology, Imaging, Cardio-Oncology, and Genetics), Hematology/Oncology, Nephrology, Neurology, Pathology, and Pharmacy to provide coordinated care.
Diagnosing & Treating Amyloidosis
Identifying the specific precursor of amyloidogenic protein is key to guiding accurate treatment and prognosis. It might require specialized imaging and a tissue biopsy, depending on each individual.
Treatment options can include chemotherapy and other newly approved medications, which are designed to slow the progression of amyloid accumulation in the affected organs. In addition, advanced heart failure therapies could be considered for some patients with significant heart involvement.
Some types of amyloidosis are hereditary and require special genetic assessment. Our Center for Cardiovascular Genetics provides this service to facilitate counseling and testing if needed.
Call 617-667-8800 or email.
Meet Our Team
Pablo Quintero Pinzon, MD
Director, Latinx Clinic; Advanced Heart Failure & Transplant Cardiology; Cardiovascular Disease
Peter Zimetbaum, MD
Co-Director, Sarcoid Center; Cardiovascular Disease; Clinical Cardiac Electrophysiology
Thomas Hauser, MD, MPH, MMSc
Director, Nuclear Cardiology; Cardiovascular Disease; Internal Medicine
Eli Gelfand, MD
Section Chief, General Cardiology; Cardiovascular Disease; Internal Medicine
Aarti Astani, MD
Stewart Lecker, MD, PhD
Program Director, Nephrology
Jessica Liegel, MD
Hematology; Medical Oncology
Christopher H. Gibbons, MD
Clinical Neurophysiology; Neurology
Roy L. Freeman, MD
Usman Tahir, MD
Director, Cardiovascular Genetics; Co-Director, HCM Clinic; Cardiovascular Disease
Caitlin Finn, MS